Immuno-psychiatry: a consortium to test the opportunity for immunotherapeutics in psychiatry

Project: Research

Project Details

StatusFinished
Effective start/end date1/10/201430/09/2016

Collaborative partners

  • King's College London (lead)
  • University of Cambridge
  • Janssen Pharmaceutica N.V.
  • GSK GlaxoSmithKline Research & Development Ltd
  • MRC Medical Research Council

Funding

  • MRC Medical Research Council: £172,986.00